The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...
The company’s lead drug candidate utilizing WaferiX is Wafermine, the world’s first patented sublingual racemic ketamine wafer for the treatment of acute moderate to severe pain and major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback